Are Normal Healthy Research Volunteers Psychologically Healthy? A Pilot Investigation

Experimental and Clinical Psychopharmacology

Volumn 15, Issue 6, 2007, Pages 539-545

  Tishler, Carl L ^a   Apseloff, Glen ^b   Bartholomae, Suzanne ^a   Reiss, Natalie Staats ^c   Rhodes, Angel R ^d   Singh, Alpana ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c HIRAM COLLEGE   (United States)

^d UNIVERSITY OF DAYTON   (United States)

Author keywords

clinical drug trials; clinical pharmacology; healthy volunteers; normal healthy research volunteer personality; research volunteers

Indexed keywords

DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEMOGRAPHY; HUMAN; MALE; MEDICAL RESEARCH; MENTAL DISEASE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; PERSONALITY TEST; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PILOT STUDY; POPULATION RESEARCH; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SOCIAL ASPECT; STATISTICAL SIGNIFICANCE; VOLUNTEER;

ADULT; HEALTH STATUS; HUMAN EXPERIMENTATION; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; MMPI; PILOT PROJECTS; QUESTIONNAIRES;

EID: 38549091176     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.15.6.539     Document Type: Article

References (48)

1. Activities Commission. Advice to health ministers on healthy volunteer studies (1987), Department of Health and Social Security, London
2. Apseloff G., Ashton H.M., Friedman H., and Gerber N. The importance of measuring nicotine levels in clinical trials. Clinical Pharmacology & Therapeutics 56 (1994) 460-462
3. Apseloff G., Swayne J., and Gerber N. Medical histories may be unreliable in screening volunteers for clinical trials. Clinical Pharmacology & Therapeutics 60 (1996) 353-356
4. Ayd F.J.J. Drug studies in prisoner volunteers. Southern Medical Journal 65 (1972) 440-444
5. Ayd F.J.J., and Calabresi P. Motivations and rewards for volunteering to be an experimental subject. Clinical Pharmacology & Therapeutics 13 (1972) 771-781
6. Ball C.J., McLaren P.M., and Morrison P.J. The personality structure of "normal" volunteers. British Journal of Clinical Pharmacology 36 (1993) 369-371
7. Berto D., Milleri S., Squassante L., and Baroldi P. Evaluation of personality as a component of the healthy condition of volunteers participating in phase I studies. European Journal of Clinical Pharmacology 51 (1996) 209-213
8. TM Minnesota Multiphasic Personality Inventory-2: Manual for administration, scoring, and interpretation, revised edition (2001), University of Minnesota Press, Minneapolis
9. Butler R.W., Jenkins M.A., and Braff D.L. The abnormality of normal comparison groups: The identification of psychosis proneness and substance abuse in putatively normal research subjects. American Journal of Psychiatry 150 (1993) 1386-1391
10. Cami J., Llorente M., Farre M., Badenas J.M., and Ugena B. Personality of healthy volunteers participating in Phase I clinical trials. Personality and Individual Differences 10 (1989) 1199-1200
11. Dahlstrom W.G., and Welch G.S. An MMPI handbook: A guide to use in clinical practice and research (1960), University of Minnesota Press, Minneapolis
12. Drici M.D., Raybaud F., De Lunardo C., Iacono P., and Gustovic P. Influence of the behavior pattern on the nocebo response of healthy volunteers. British Journal of Clinical Pharmacology 39 (1995) 204-206
13. Esecover H., Malitz S., and Wilkens B. Clinical profiles of paid normal subjects volunteering for hallucinogen drug studies. American Journal of Psychiatry 117 (1961) 910-915
14. Eysenck H.J., and Eysenck S.B.G. Eysenck Personality Inventory (1968), Educational and Industrial Testing Service, San Diego, CA
15. Fahrenberg J., and Selg H. Das Freiburger Personlichkietsinventar (FPI): Handanweisung (1970), Hogrefe, Gottingen, Germany
16. Farre M., Lamas X., and Cami J. Sensation seeking amongst healthy volunteers participating in phase I clinical trials. British Journal of Clinical Pharmacology 39 (1995) 405-409
17. Feldman P.J., Cohen S., Doyle W.J., Skoner D.P., and Gwaltney J.M.J. The impact of personality on the reporting of unfounded symptoms and illness. Journal of Personality and Social Psychology 77 (1999) 370-378
18. Graham J.R. The MMPI-2: Assessing personality and psychopathology. 4th ed. (2006), Oxford University Press, New York
19. Graham J.R., Barthlow D.L., Stein L.A.R., Ben-Porath Y.S., and McNulty J.L. Assessing general maladjustment with the MMPI-2. Journal of Personality Assessment 78 (2002) 334-347
20. Graham J.R., Watts D., and Timbrook R.E. Detecting fake-good and fake-bad MMPI-2 profiles. Journal of Personality Assessment 57 (1991) 264-277
21. Green R.L. The MMPI-2: An interpretive manual (2000), University of Minnesota Press, Minneapolis
22. Gross C.P., Mallory R., Heiat A., and Krumholz H.M. Reporting the recruitment process in clinical trials: Who are these patients and how did they get there?. Annals of Internal Medicine 137 (2002) 10-16
23. Hartzema A.G., Pancorbo S., and Davis S. Personality traits and theophylline metabolism. Biopharmaceutics & Drug Disposition 3 (1982) 311-316
24. Heisel J.S., Locke S.E., Kraus L.J., and Williams R.M. Natural killer cell activity and MMPI scores of a cohort of college students. American Journal of Psychiatry 143 (1986) 1382-1386
25. Kruesi M.J., Lenane M.C., Hibbs E.D., and Major J. Normal controls and biological reference values in child psychiatry: Defining normal. Journal of the American Academy of Child and Adolescent Psychiatry 29 (1990) 449-452
26. Lebacqz K. Controlled clinical trials: Some ethical issues. Controlled Clinical Trials 1 (1980) 29-36
27. Lemonick M.D., and Goldstein A. At your own risk. Time 159 16 (2002, April 22) 46-56
28. Macrae F.A., Mackay I.R., and Fraser J.R. Participation of healthy volunteers in research projects. The Medical Journal of Australia 150 (1989) 325-328
29. Meyer F.P. Psycho- and immunopharmacological factors relevant to selection of volunteers in clinical studies. International Journal of Clinical Pharmacology and Therapeutics 39 (2001) 300-310
30. Meyer F.P., Haschke R., and Rohl F.W. The healthy volunteer in clinical pharmacology: Personality and motivation. European Journal of Clinical Pharmacology 48 (1995) 91-96
31. Meyer F.P., Troger U., Ansorge S., Ittenson A., Bank U., Buhling F., et al. Dominance personality trait and immune system in healthy volunteers. Human Psychopharmacology 13 (1998) 183-189
32. Meyer F.P., Troger U., and Rohl F.W. Adverse nondrug reactions: An update. Clinical Pharmacology & Therapeutics 60 (1996) 347-352
33. Meyer F.P., Walther H., and Kohler E. Zum einflub des personlichkeitsmermals "emotionale labilitat" auf die gastrointestinale resorption von coffein [Concerning the influence of the personality trait "emotional lability" on the gastrointestinal resorption of caffeine]. Zentralblatt fur Pharmazie 121 (1982) 871-876
34. Morselli P.L. Are phase I studies without drug level determination acceptable?. Fundamental and Clinical Pharmacology 4 Suppl. 2 (1990) 125s-133s
35. Nakano S., Ogawa N., and Kawazu Y. Influence of neuroticism on oral absorption of diazepam. Clinical Pharmacology & Therapeutics 27 (1980) 370-374
36. Novak E., Seckman C.E., and Stewart R.D. Motivations for volunteering as research subjects. Journal of Clinical Pharmacology 17 (1977) 365-371
37. Ong D., Popat A., Knowles S.R., Arrowood J.S., Shear N.H., and Binkley K.E. Objective psychological measurement and clinical assessment of anxiety in adverse drug reactions. Canadian Journal of Clinical Pharmacology 11 (2004) e8-e16
38. Pieters M.S., Jennekens-Schinkel A., Schoemaker H.C., and Cohen A.F. Self-selection for personality variables among healthy volunteers. British Journal of Clinical Pharmacology 33 (1992) 101-106
39. Pollin W., and Perlin S. Psychiatric evaluation of "normal control" volunteers. American Journal of Psychiatry 115 (1958) 129-133
40. Purcell D.W., Schwartz J.A., Brookshire R.J., Caudle J., and Lewine R.R. Neuropsychological functioning in "normal" subjects. Neuropsychiatry, Neuropsychology, & Behavioral Neurology 8 (1995) 6-13
41. Schechter D., Singer T.M., Kuperman J., and Endicott J. Selection of "normal" control subjects for psychiatric research: Update on a model for centralized recruitment. Psychiatry Research 79 (1998) 175-185
42. Shtasel D.L., Gur R.E., Mozley P.D., Richards J., Taleff M.M., and Heimberg C. Volunteers for biomedical research. Recruitment and screening of normal controls. Archives of General Psychiatry 48 (1991) 1022-1025
43. Thaker G.K., Moran M., Lahti A., Adami H., and Tamminga C. Psychiatric morbidity in research volunteers. Archives of General Psychiatry 47 (1990) 980
44. Tishler C.L., and Bartholomae S. Repeat participation among normal healthy volunteers: Professional guinea pigs in clinical trials?. Perspectives in Biology and Medicine 4 (2003) 508-520
45. Tishler C.L., Bartholomae S., and Rhodes A.R. Personality profiles of normal healthy research volunteers: A potential concern for clinical drug trial investigators?. Medical Hypotheses 65 (2005) 1-7
46. Tishler C.L., and Gordon L.B. Ethical parameters of challenge studies inducing psychosis with ketamine. Ethics and Behavior 9 (1999) 211-217
47. TM) auf die reaktionsfahigkeit und die subjective Befindlichkeit gesunder Probnden - ein Beitrag zur differentiellen Psychopharmakologie [The influence of diazepam (Faustan) on the ability to react and the subjective condition of healthy personality-a contribution to discriminating psychopharmacology]. Zeitschrift fur klinische Medizin 40 (1985) 673-676
48. Weissman L., Moore J.D., Thomas G.B., and Whitman E.N. Personality factors in prison volunteers related to response in clinical drug trials. Journal of Clinical Pharmacology and New Drugs 12 (1972) 5-10